NDAOPHTHALMICOINTMENT
Approved
Jun 1958
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 16h ago · AI intelligence enriched 22h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
OPHTHOCORT is a combination ophthalmic ointment containing chloramphenicol (broad-spectrum antibiotic), hydrocortisone acetate (corticosteroid), and polymyxin B sulfate (antibiotic) used to treat bacterial eye infections with inflammatory components. The triple-agent formulation addresses both infection and inflammation simultaneously in ocular conditions. This product represents a legacy fixed-combination approach to managing bacterial conjunctivitis and keratitis.
LOE Approaching
Legacy product nearing loss of exclusivity with moderate competitive pressure (30/100); team likely in maintenance or transition mode rather than growth investment.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on OPHTHOCORT offers limited career growth given its LOE-approaching status and minimal linked job openings; roles focus on maximizing remaining revenue and managing competitive decline rather than market expansion. This assignment is best suited for professionals seeking specialty ophthalmology experience or cost-management expertise, but carries reputational risk if portfolio is perceived as legacy or declining.
Brand Manager
Worked on OPHTHOCORT at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.